| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f533a36c2405d0722ebd5ca0df1726c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1de45a0e880d955a8ebd2caf8c2b7395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8ce65118615ac79195c1a1d87377cce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1744b250b6add0812779cc7003c69117 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91541 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10 |
| filingDate |
2008-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb035fb935c383b8425ff3aef61d7c01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9a7112af4a62cafa68ca4bc09f3deea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db1c3d820f31b2cd1ca899291aa128f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fcd0862e51d221c3e4523981e867c8f |
| publicationDate |
2008-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008137547-A1 |
| titleOfInvention |
Drug eluting stents with prolonged local elution profiles high local concentrations and low systemic concentrations |
| abstract |
A drug eluting stent can include a stent body having a polymeric coating with a lipophilic and/or hydrophilic element. A drug that has a bioactivity that inhibits cell proliferation can be disposed in the polymeric coating. The drug can be present in the polymer at an amount greater than or equal to about 150 ug/cm2. The polymeric coating and drug are configured to cooperate so as to form a diffusion pathway with tissue when the stent is disposed in a body lumen such that the drug preferentially diffuses into the tissue over a body fluid passing through the body lumen such that a maximum systemic blood concentration of the drug is less than about 40 ng/ml. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9414901-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8974517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011189255-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9358096-B2 |
| priorityDate |
2007-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |